Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 28;17(8):1036-44.
doi: 10.3748/wjg.v17.i8.1036.

miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus

Affiliations

miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus

Cameron M Smith et al. World J Gastroenterol. .

Abstract

Aim: To investigate miR-200 family expression in Barrett's epithelium, gastric and duodenal epithelia, and esophageal adenocarcinoma.

Methods: Real-time reverse transcriptase-polymerase chain reaction was used to measure miR-200, ZEB1 and ZEB2 expression. Ingenuity Pathway Analysis of miR-200 targets was used to predict biological outcomes.

Results: Barrett's epithelium expressed lower levels of miR-141 and miR-200c than did gastric and duodenal epithelia (P < 0.001). In silico analysis indicated roles for the miR-200 family in molecular pathways that distinguish Barrett's epithelium from gastric and duodenal epithelia, and which control apoptosis and proliferation. All miR-200 members were downregulated in adenocarcinoma (P < 0.02), and miR-200c expression was also downregulated in non-invasive epithelium adjacent to adenocarcinoma (P < 0.02). The expression of all miR-200 members was lower in Barrett's epithelium derived high-grade dysplastic cell lines than in a cell line derived from benign Barrett's epithelium. We observed significant inverse correlations between miR-200 family expression and ZEB1 and ZEB2 expression in Barrett's epithelium and esophageal adenocarcinoma (P < 0.05).

Conclusion: miR-200 expression might contribute to the anti-apoptotic and proliferative phenotype of Barrett's epithelium and regulate key neoplastic processes in this epithelium.

Keywords: Apoptosis; Barrett’s esophagus; Epithelial to mesenchymal transition; Epithelium; Esophageal adenocarcinoma; Proliferation; miR-200; miRNA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Top associated network functions for miR-141 and miR-200c. A: Ingenuity Pathway Analysis predicted that the top associated network functions for miR-141 were gene expression, cell death and cell cycle (P = 1 × 10-35). B: The top associated network functions for miR-200c were cell morphology, cellular assembly and organization, cellular function and maintenance (P = 1 × 10-38). Predicted targets of miR-141 or miR-200c are highlighted in grey. Uncolored entries represent molecules that are associated with the pathway but are not predicted miR-141 or miR-200c targets. The P values were derived from a right-tailed Fisher’s exact test to calculate the probability that each predicted miRNA target matches the ascribed network function due to chance alone.
Figure 2
Figure 2
miR-200 family expression in benign Barrett’s and dysplastic cell lines. Relative expression of all miR-141, miR-200a, miR-200b and miR-429, normalized to U44 expression is shown on the left hand y axis. Relative expression of miR-200c is shown on the right hand y axis. The pattern of relative expression of miR-200 members in the Qh (benign Barrett’s) cell line closely resembled that in benign Barrett’s esophagus mucosa (see relative expression values in Table 1).

Similar articles

Cited by

References

    1. Orlando RC. Mucosal Defense in Barrett’s Esophagus. In Barrett’s Esophagus and Esophageal Adenocarcinoma. Sharma P, editor. Oxford, UK: Blackwell Publishing, Ltd; 2006. pp. 60–72.
    1. Zwas F, Shields HM, Doos WG, Antonioli DA, Goldman H, Ransil BJ, Spechler SJ. Scanning electron microscopy of Barrett’s epithelium and its correlation with light microscopy and mucin stains. Gastroenterology. 1986;90:1932–1941. - PubMed
    1. Levine DS, Rubin CE, Reid BJ, Haggitt RC. Specialized metaplastic columnar epithelium in Barrett’s esophagus. A comparative transmission electron microscopic study. Lab Invest. 1989;60:418–432. - PubMed
    1. Barrett MT, Yeung KY, Ruzzo WL, Hsu L, Blount PL, Sullivan R, Zarbl H, Delrow J, Rabinovitch PS, Reid BJ. Transcriptional analyses of Barrett’s metaplasia and normal upper GI mucosae. Neoplasia. 2002;4:121–128. - PMC - PubMed
    1. van Baal JW, Milano F, Rygiel AM, Bergman JJ, Rosmolen WD, van Deventer SJ, Wang KK, Peppelenbosch MP, Krishnadath KK. A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology. 2005;129:1274–1281. - PubMed

Publication types

MeSH terms